featured
CYP2D6 Genotype Predicts Tamoxifen Discontinuation and Drug Response
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
CYP2D6 Genotype Predicts Tamoxifen Discontinuation and Drug Response: A Secondary Analyses of the KARISMA Trial
Ann. Oncol 2021 Jul 17;[EPub Ahead of Print], W He, M Eriksson, E Eliasson, F Grassmann, M Bäcklund, M Gabrielson, M Hammarström, S Margolin, L Thorén, Y Wengström, S Borgquist, P Hall, K CzeneFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.